Guardian Pharmacy Service... (GRDN)

AI Score

Unlock

24.09

0.00 (0.00%)

At close: Apr 25, 2025, 3:59 PM

24.20

0.46%

After-hours: Apr 25, 2025, 04:07 PM EDT

Guardian Pharmacy Services Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q1 2021	Q4 2020	Q3 2020	Q1 2020	Q4 2019	Q4 2018
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Mar 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	1.23B	1.16B	1.1B	1.05B	989.2M	937.51M	893.96M	848.6M	805.84M	783.32M	755.1M	736.95M	738.42M	549.89M	529.28M	343.85M	161.06M
Cost of Revenue	990.22M	929.3M	878.9M	837.88M	789.14M	747.66M	712.49M	676.78M	645.46M	627.91M	606.58M	592.58M	591.12M	439.6M	422.19M	274.17M	129.2M
Gross Profit	243.85M	228.94M	218.38M	208.31M	200.06M	189.85M	181.47M	171.82M	160.37M	155.41M	148.53M	144.37M	147.31M	110.29M	107.09M	69.68M	31.86M
Operating Income	-55.33M	-78.41M	51.49M	40.95M	23.76M	51.6M	25.03M	34.37M	38.42M	29.49M	30.45M	16.83M	22.89M	10.3M	13.31M	11.13M	2.69M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-59.01M	-82.23M	47.85M	37.72M	21M	49.02M	22.83M	32.51M	36.67M	27.62M	28.54M	14.63M	20.39M	8.42M	11.26M	9.79M	2.03M
Net Income	-78.06M	-101.29M	32.82M	23.9M	5.94M	35.2M	8.81M	19.38M	25.25M	16.95M	18.66M	5.41M	10.92M	1.25M	4.72M	5.71M	261K
Selling & General & Admin	299.18M	307.35M	166.89M	167.36M	176.3M	149.5M	175.92M	154.38M	135.87M	124.98M	105.68M	114.77M	111.91M	91.07M	85.96M	53.65M	27.03M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	-11.24M	-19.48M	-16.93M	-13.91M	933K	12.4M	12.77M	12.51M	8.91M	7.82M	4.9M	2.14M
Operating Expenses	299.18M	307.35M	166.89M	167.36M	176.3M	138.25M	156.44M	137.45M	121.95M	125.92M	118.08M	127.54M	124.42M	99.98M	93.77M	58.55M	29.17M
Interest Expense	3.25M	3.55M	3.22M	2.86M	2.54M	2.23M	1.93M	1.63M	1.63M	1.66M	1.76M	1.99M	2.11M	1.67M	1.76M	1.12M	582K
Selling & Marketing Expenses	n/a	n/a	37.02M	73.86M	107.52M	139.24M	140.63M	127.03M	122.84M	111.95M	105.68M	114.77M	111.91M	91.07M	85.96M	53.65M	27.03M
Cost & Expenses	1.29B	1.24B	1.05B	1.01B	965.44M	885.91M	868.93M	814.23M	767.42M	753.83M	724.66M	720.12M	715.54M	539.58M	515.97M	332.71M	158.37M
Income Tax Expense	4.56M	176K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	n/a	61.14M	60.84M	n/a	60.84M	60.84M	60.84M	60.84M	60.84M	n/a	60.84M	60.84M	n/a	60.84M	60.84M	n/a	n/a
Shares Outstanding (Diluted)	n/a	61.14M	60.84M	n/a	60.84M	60.84M	60.84M	60.84M	60.84M	n/a	60.84M	60.84M	n/a	60.84M	60.84M	n/a	n/a
EPS (Basic)	-1.83	-2.02	0.33	0.19	0.09	0.58	0.23	0.40	0.50	0.20	0.15	-0.07	-0.07	-0.07	-0.02	n/a	n/a
EPS (Diluted)	-1.83	-2.02	0.33	0.19	0.09	0.58	0.23	0.40	0.50	0.20	0.15	-0.07	-0.07	-0.07	-0.02	n/a	n/a
EBITDA	-40.9M	-64.34M	64.85M	58.81M	41.08M	68.22M	41.43M	49.06M	53.46M	44.73M	44.65M	32.45M	38.34M	21.56M	25.03M	18.73M	6.16M
EBIT	-55.76M	-78.68M	51.08M	40.58M	23.54M	51.25M	24.76M	34.14M	38.29M	29.28M	30.3M	16.62M	22.51M	10.09M	13.02M	10.91M	2.61M
Depreciation & Amortization	14.86M	14.35M	13.78M	18.23M	17.54M	16.97M	16.67M	14.92M	15.16M	15.46M	14.34M	15.83M	15.83M	11.47M	12.01M	7.82M	3.55M